Skip to content
★ Sign in to follow
JC
Total declarations
169
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (107 ops.)
€33.3M

Latest filing published 23 Apr 2020 for Abbott Laboratories, €1.9M.

Filing timeline

BuySale
Jaime Contreras

Insider track record

Disclosed buys
0
Disclosed sells
107
Signal history

Jaime Contreras: trading record in brief

Jaime Contreras discloses dealings in Abbott Laboratories to SEC (Form 4). Over a trading history stretching from 30 October 2013 to 21 April 2020, the count stands at 169 filings.

Every open-market trade on record is a sale: 107 sales worth €33.3M. Other entries cover 36 share grants and 23 option exercises. 2020 to date brings no purchases and 1 sale.

The record was last updated on 23 April 2020 with an option exercise (€1.9M) in Abbott Laboratories. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Jaime Contreras

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations168 total
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD12SEC
    46,016 shares@ US$44.4013.6% of flowCommon shares without par valueSEC:0001179110-20-005067:0
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD12SEC
    36,715 shares@ US$59.9414.6% of flowCommon shares without par valueSEC:0001179110-20-005067:1
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD12SEC
    25,681 shares@ US$75.9012.9% of flowCommon shares without par valueSEC:0001179110-20-005067:2
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    8M USD16SEC
    83,226 shares@ US$98.0054.1% of flowCommon shares without par valueSEC:0001179110-20-005067:3
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    27,214 USD11SEC
    343 shares@ US$79.340.2% of flowCommon shares without par valueSEC:0001179110-20-004340:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    740 shares0Common shares without par valueSEC:0001179110-20-004340:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    549,262 USD11SEC
    6,936 shares@ US$79.193.6% of flowCommon shares without par valueSEC:0001179110-20-002897:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    155,858 USD29SEC
    2,001 shares@ US$77.891.0% of flowCommon shares without par valueSEC:0001179110-20-002897:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    11,250 shares0Common shares without par valueSEC:0001179110-20-002272:0
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD11SEC
    46,016 shares@ US$44.402.4% of flowCommon shares without par valueSEC:0001179110-19-005257:0
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    2M USD11SEC
    36,716 shares@ US$59.942.6% of flowCommon shares without par valueSEC:0001179110-19-005257:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    5M USD24SEC
    70,400 shares@ US$70.005.8% of flowCommon shares without par valueSEC:0001179110-19-005257:2
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    863,487 USD23SEC
    12,332 shares@ US$70.021.0% of flowCommon shares without par valueSEC:0001179110-19-005257:3
  • ◇
    Senior Vice PresidentExecutivesAbbott Laboratories
    3M USD11SEC
    80,860 shares@ US$38.403.6% of flowCommon shares without par valueSEC:0001179110-19-005257:4
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    5M USD12SEC
    57,962 shares@ US$78.115.3% of flowCommon shares without par valueSEC:0001179110-19-005257:5
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    67,124 USD23SEC
    918 shares@ US$73.120.1% of flowCommon shares without par valueSEC:0001179110-19-005146:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    0SEC
    935 shares0Common shares without par valueSEC:0001179110-19-004549:0
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    30,777 USD11SEC
    385 shares@ US$79.940.0% of flowCommon shares without par valueSEC:0001179110-19-004549:1
  • ◆
    Senior Vice PresidentExecutivesAbbott Laboratories
    771,682 USD11SEC
    9,992 shares@ US$77.230.9% of flowCommon shares without par valueSEC:0001179110-19-003113:0
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    15,662 USD29SEC
    200 shares@ US$78.310.0% of flowCommon shares without par valueSEC:0001179110-19-003113:1
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    23,490 USD29SEC
    300 shares@ US$78.300.0% of flowCommon shares without par valueSEC:0001179110-19-003113:2
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    7,830 USD29SEC
    100 shares@ US$78.300.0% of flowCommon shares without par valueSEC:0001179110-19-003113:3
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    46,980 USD29SEC
    600 shares@ US$78.300.1% of flowCommon shares without par valueSEC:0001179110-19-003113:4
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    23,487 USD29SEC
    300 shares@ US$78.290.0% of flowCommon shares without par valueSEC:0001179110-19-003113:5
  • ▼
    Senior Vice PresidentExecutivesAbbott Laboratories
    104,361 USD29SEC
    1,333 shares@ US$78.290.1% of flowCommon shares without par valueSEC:0001179110-19-003113:6

25 of 168 declarations